✦ LIBER ✦

Hepatitis C virus infection in kidney transplant recipients

✍ Scribed by Johnson Y. N. Lau; Gary L. Davis; Mathew E. Brunson; Ke-Ping Qian; Hsiang-Ju Lin; Stella Quan; Robert Dinello; Alan J. Polito; Juan C. Scornik

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 581 KB
Volume: 18
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840180502

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fibrosing cholestatic hepatitis in renal

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection

✍ Delladetsima, Johanna K. ;Boletis, John N. ;Makris, Fotis ;Psichogiou, Mina ;Kos 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 445 KB

Fibrosing cholestatic hepatitis (FCH) has been described as a specific manifestation of hepatitis B virus (HBV) infection in liver allograft recipients characterized by a rapid progression to liver failure. Only sporadic cases have been reported in other immunocompromised groups infected with HBV an

Chronic hepatitis E virus infection in l

Chronic hepatitis E virus infection in liver transplant recipients

✍ Elizabeth B. Haagsma; Arie P. van den Berg; Robert J. Porte; Cornelis A. Benne; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 1 views

Hepatitis E virus (HEV) infection is known to run a self-limiting course. Sporadic cases of acute hepatitis due to infection with HEV genotype 3, present in pig populations, are increasingly recognized. Zoonotic transmission seems infrequent. The entity of unexplained chronic hepatitis after liver t

Treating hepatitis C infection in liver

Treating hepatitis C infection in liver transplant recipients

✍ Norah A. Terrault; Marina Berenguer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 1 views

Chronic infection with hepatitis C virus (HCV) is a growing problem worldwide, with up to 300 million individuals infected, and those with chronic infection are at risk for cirrhosis and hepatocellular carcinoma. HCV infection is the most common indication for liver transplantation in the United Sta

Prevalence of hepatitis E virus infectio

Prevalence of hepatitis E virus infection in liver transplant recipients

✍ Elizabeth B. Haagsma; Hubert G. M. Niesters; Arie P. van den Berg; Annelies Riez 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Hepatitis E virus (HEV) infection is known to run a self-limited course. Recently, chronic hepatitis E has been described in several immunosuppressed patients after solid organ transplantation. The prevalence of HEV infection after transplantation, however, is unknown. We studied HEV parameters [HEV

Ganciclovir treatment of hepatitis B vir

Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients

✍ R G Gish; J Y Lau; L Brooks; J W S Fang; S L Steady; J C Imperial; R Garcia-Kenn 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

To determine the safety and efficacy of ganciclovir usually experience progressive liver disease over an treatment of hepatitis B virus (HBV) infection after liver accelerated time course and pose a difficult managetransplantation, nine patients (seven males, two females; ment challenge. The treatm

Unexpected distribution of hepatitis C v

Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients

✍ Renata M. Perez; Maria Lucia G. Ferraz; Mauro S. Figueiredo; Denilson Contado; S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

## Abstract The distribution of hepatitis C virus (HCV) genotypes in patients on hemodialysis and in kidney transplant recipients was compared with that observed in a control group composed of HCV‐infected individuals from the general population. A total of 340 patients were included in the study: